Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Gains from Sales and Divestitures (2018 - 2024)

Historic Gains from Sales and Divestitures for STRATA Skin Sciences (SSKN) over the last 7 years, with Q4 2024 value amounting to $2265.0.

  • STRATA Skin Sciences' Gains from Sales and Divestitures fell 8737.74% to $2265.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $2265.0, marking a year-over-year decrease of 8737.74%. This contributed to the annual value of $2265.0 for FY2024, which is 8737.74% down from last year.
  • Latest data reveals that STRATA Skin Sciences reported Gains from Sales and Divestitures of $2265.0 as of Q4 2024, which was down 8737.74% from $2265.0 recorded in Q3 2024.
  • In the past 5 years, STRATA Skin Sciences' Gains from Sales and Divestitures registered a high of $158407.0 during Q4 2022, and its lowest value of $1414.0 during Q2 2024.
  • In the last 5 years, STRATA Skin Sciences' Gains from Sales and Divestitures had a median value of $55547.0 in 2020 and averaged $64465.6.
  • As far as peak fluctuations go, STRATA Skin Sciences' Gains from Sales and Divestitures soared by 29866.0% in 2023, and later crashed by 9822.65% in 2024.
  • STRATA Skin Sciences' Gains from Sales and Divestitures (Quarter) stood at $68091.0 in 2020, then skyrocketed by 114.95% to $146364.0 in 2021, then increased by 8.23% to $158407.0 in 2022, then plummeted by 88.67% to $17944.0 in 2023, then crashed by 87.38% to $2265.0 in 2024.
  • Its Gains from Sales and Divestitures stands at $2265.0 for Q4 2024, versus $2265.0 for Q3 2024 and $1414.0 for Q2 2024.